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Abstract
The conclusions of thousands of peer-reviewed publications rely on data obtained using fluorescence-based quan-
titative real-time PCR technology. However, the inadequate reporting of experimental detail, combined with the
frequent use of flawed protocols is leading to the publication of papers that may not be technically appropriate.
We take the view that this problem requires the delineation of a more transparent and comprehensive reporting
policy from scientific journals. This editorial aims to provide practical guidance for the incorporation of absolute
minimum standards encompassing the key assay parameters for accurate design, documentation and reporting of
qPCR experiments (MIQE précis) and guidance on the publication of pure ‘reference gene’ articles.
Background
Fluorescence-based quantitative real-time PCR (qPCR) is
commonly regarded as a straightforward, mature tech-
nology and has become a ubiquitous mainstay of mole-
cular biology. However, obtaining, analysing and
interpreting qPCR data is not a trivial issue. The pro-
gressive relegation of qPCR materials and methods to
online supplements is resulting in an increasing ten-
dency for scientific publications to contain insufficient
technical information for that work to be reproduced;
frequently that information is lacking altogether. Equally
disconcertingly, the modest details included with publi-
cations frequently reveal the use of flawed practices that
are likely to result in the publication of erroneous con-
clusions. This often makes it impossible for reviewers
and readers to judge a manuscript’s technical adequacy,
whilst impeding journal editors’ ability to reach publica-
tion decisions based on its validity and coherence.
A set of “MIQE” guidelines proposes a minimum stan-
dard for the provision of information for publications
utilising qPCR experiments [1]. These cover every aspect
of sample acquisition, assay design and validation and
data analysis, to provide an ideal tool for the design of
de novo assays and are invaluable for guiding reviewers,
as well as assisting decision-making by journal editors.
However, their exhaustive incorporation of numerous
assay-associated details can appear daunting to non-
qPCR experts and may render them too complex for the
routine reporting of established assays. Consequently,
we would like to propose an abridged set of guidelines
for covering key parameters of every qPCR assay (MIQE
précis). These cover those steps of a qPCR assay that
are essential for allowing reviewers, editors and readers
to evaluate the technical merits of scientific publications
utilising qPCR technology (Figure 1).
Sample/template
As sample handling affects experimental variability, it is
essential to report tissue source and to provide informa-
tion about conditions of storage, particularly if samples
have been obtained during the course of a longitudinal
study stretching over several years. Any deviations from
manufacturers’ protocols must be recorded. For RNA
templates, the extent of residual genomic DNA contami-
nation must be reported, ideally for each sample, or if
numerous samples are being used, for a representative
set of samples, by comparing quantification cycles (Cq)
obtained with and without reverse transcription (RT) for
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each nucleic acid target. Where RNA quantities are
ample for accurate RNA measurement, both quantity
and quality of extracts should be recorded. Although no
perfect quality assessment methods exist, measurements
such as those obtained from microfluidics-based systems
or 3’:5’-type assays can serve as basic indicators of RNA
integrity [2]. Authors should not quantitatively compare
RNAs of widely dissimilar quality, e.g., RIN/RQI values
of 4.5 versus 9.5, and be aware that rRNAs yielding
similar RIN/RQI numbers can contain mRNAs that dif-
fer significantly in their integrity. Every sample or, in
the case of very large numbers, representative samples,
should also be tested for the absence of inhibitors using
either an “alien” spike or a dilution series of target
genes.
Assay optimisation/validation
Database accession numbers, amplicon size and primer
sequences must be reported for each target. We would
recommend that probe sequences and the identities,
positions, and linkages of any dyes and/or modified bases
are also reported. We encourage the use of validated
assays, e.g. those available from RTPrimerDB, as this
helps with assay standardisation and does not require
extensive validation. For newly reported assays, the use of
primer design software is encouraged. Primer specificity
should be validated in silico (BLAST specificity analysis)
and empirically (ideally by DNA sequencing, but certainly
using gel electrophoresis or melting profiles). Evidence
for the optimisation of primer and MgCl2 concentration,
as well as that of the annealing temperature should be
provided and the PCR efficiency of each assay should be
reported. This is most conveniently performed by means
of calibration curves, which must be included for review,
although only slopes, y intercepts, linear dynamic range
and LOD need be included with the publication. A mea-
sure of intra-assay variation (repeatability) and for diag-
nostic assays inter-assay precision (reproducibility)
between sites and different operators should also be
reported. For multiplexing it is also essential to demon-
strate that accurate quantification of multiple targets in a
single tube is not impaired.
Figure 1 Key criteria delineating essential technical information required for the assessment of a RT-qPCR experiment .
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Reverse transcription qPCR (RT-qPCR)
Experimental conditions and reagents must be described
in detail, especially what priming method has been used
for cDNA synthesis. For RT-qPCR assays total RNA
concentration should be similar in every sample and we
encourage replicates of the RT step to improve reliabil-
ity. In addition to the DNA contamination control,
which need be run only once for each sample, other
important controls include:
1. no template controls (NTC). These are essential
for detecting PCR contamination and must be per-
formed with every experiment. They help establish
conditions for data rejection from assays utilising
SYBR Green chemistry, where primer dimers may
result in positive Cqs being recorded in the NTCs.
NTCs should be the last samples to be dispensed
and loaded.
2. positive controls. These are most conveniently
performed as target gene-specific dilution curves and
are essential if PCR measurements are of low copy
numbers and where it is essential to have confidence
in a negative result, for example when detecting
pathogens.
3. no amplification controls (NAC). These provide
valuable information when using probes, as they
help monitor any probe degradation.
Data analysis
We encourage the use of specialist software for data
analysis, confidence estimation and outlier identification.
The handling of such data must be specified as well as
the statistical methods used to evaluate assay precision.
Information relating to experimental lay-out must be
supplied: we encourage the use of a sample maximisa-
tion strategy, i.e., running as many samples as possible
in the same run, as opposed to a gene maximisation
strategy that analyses multiple genes in the same run.
This is because it minimises any technical, run-to-run
variation between different samples for the comparison
of gene expression levels. If not all samples can be ana-
lysed in the same run, identical samples that are tested
in both runs ("inter-run calibrators” or IRCs) must be
analysed. Measuring the difference in Cq or the normal-
ised relative quantity between the IRCs in different runs
allows the calculation of a correction or calibration fac-
tor to remove run-to-run differences [3].
Normalisation with reference genes
This is an essential component of a reliable qPCR assay:
1. mRNA data are most commonly normalised using
reference genes as internal controls. Their utility
must be validated experimentally for particular tis-
sues or cell types using the specific experiment in
question. Unless fully validated single reference
genes are used, normalisation should be performed
against multiple reference genes, chosen from a suf-
ficient number of candidate reference genes tested
from independent pathways using at least one algo-
rithm (e.g., GeNorm). In general, the use of fewer
than three reference genes is not advisable and rea-
sons for choosing fewer must be specifically
addressed.
2. For large-scale miRNA expression profiling
experiments normalisation should be performed
against the mean expression value of all expressed
miRNAs. For small scale experiments, pilot experi-
ments analogous to those used for mRNA reference
gene selection should be used to identify suitable
reference miRNAs. It is worth noting that miRNAs
isolation should be carried out using specialised
extraction protocols, as the efficiency of miRNA
extraction is reagent-dependent and can be
variable.
In recent years, biomedical journals, such as BMC
Molecular Biology, have experienced a trend towards
increased submissions of so-called ‘reference gene
papers’, i.e., manuscripts that evaluate the stability of
candidate reference genes under certain experimental
conditions. While some of those studies might have pro-
vided helpful guidelines for other researchers, it is has
long been undisputed that the utility of chosen reference
genes must be confirmed by each research group for
every experimental setup. This renders pure ‘reference
gene papers’ pointless. Consequently, the signing editor-
ial board members suggest that ‘reference gene papers’
should no longer be publishable in BMC Molecular
Biology, except for those that:
1. Demonstrate the use of the selected reference
genes for further investigations, e.g., to normalize
RT-qPCR data of target genes as part of a larger
study
2. Introduce and validate a novel approach for refer-
ence gene identification or normalisation, e.g., algo-
rithms or software
3. Highlight rare cases or a standardized experimen-
tal setup of outstanding importance.
However, ‘reference gene papers’ that do not meet the
criteria outlined here may still be suitable for peer
review in other journals such as BMC Research Notes.
These papers are available and will continue to be col-
lated in a topical series (Quantitative Real Time PCR
normalization and optimization).
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A (RT)-qPCR checklist listing the minimum technical
information required for publication in BMC Molecular
Biology is shown in Table 1. This information can be
used by the reviewers to assess the technical adequacy
of the qPCR protocols, with a sentence in the published
paper stating that the minimal guidelines have been
adhered to. We propose that these details are included
on submission as a supplemental file (please see the
template included as additional file 1) for the reviewers’
benefit, and, once accepted, become part of the supple-
mentary data published online.
Conclusions
It is becoming increasingly obvious that it is no longer
possible to assess the technical adequacy of qPCR-based
peer-reviewed publications by scrutinising either their
materials and methods or online supplements sections.
We propose the above guidance to uphold the quality of
research published in BMC Molecular Biology and to
help standardise the way in which qPCR-based experi-
ments and data are reported.
Additional material
Additional file 1: MIQE précis template for including as
supplemental files in submitted manuscripts. *Strongly encouraged.
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Table 1 Checklist for authors’ of MIQE précis at time of manuscript submission, detailing information about individual
parameters associated with each step of the RT-qPCR workflow
Sample/Template details
Source If cancer, was biopsy screened for adjacent normal tissue?
Method of preservation Liquid N2/RNAlater/formalin
Storage time (if appropriate) If using samples >6 months old
Handling fresh/frozen/formalin
Extraction method TriZol/columns
RNA: DNA-free Intron-spanning primers/no RT control
Concentration Nanodrop/ribogreen/microfluidics
RNA: integrity Microfluidics/3′:5′ assay
Inhibition-free Method of testing
Assay optimisation/validation
Accession number RefSeq XX_1234567
Amplicon details exon location, amplicon size
Primer sequence even if previously published
Probe sequence* identify LNA or other substitutions
In silico BLAST/Primer-BLAST/m-fold
empirical primer concentration/annealing temperature
Priming conditions oligo-dT/random/combination/target-specific
PCR efficiency dilution curve
Linear dynamic range spanning unknown targets
Limits of detection LOD detection/accurate quantification
Intra-assay variation copy numbers not Cq
RT/PCR
Protocols detailed description, concentrations, volumes
Reagents supplier, Lot number
Duplicate RT ΔCq
NTC Cq & melt curves
NAC ΔCq beginning:end of qPCR
Positive control inter-run calibrators
Data analysis
Specialist software e.g., QBAsePlus
Statistical justification e.g., biological replicates
Transparent, validated normalisation e.g., GeNorm summary
*Disclosure of probe sequences is strongly encouraged.
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